IOL CHEMICALS & PHARM. | UNJHA FORMUL | IOL CHEMICALS & PHARM./ UNJHA FORMUL |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 37.2 | 36.7% | View Chart |
P/BV | x | 1.6 | 3.5 | 44.2% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. UNJHA FORMUL |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
UNJHA FORMUL Mar-23 |
IOL CHEMICALS & PHARM./ UNJHA FORMUL |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 20 | 2,683.5% | |
Low | Rs | 272 | 8 | 3,303.4% | |
Sales per share (Unadj.) | Rs | 377.6 | 29.4 | 1,286.2% | |
Earnings per share (Unadj.) | Rs | 23.7 | 0.6 | 3,751.7% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 0.8 | 3,938.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 5.5 | 4,690.2% | |
Shares outstanding (eoy) | m | 58.71 | 4.48 | 1,310.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.5 | 222.7% | |
Avg P/E ratio | x | 17.1 | 22.4 | 76.2% | |
P/CF ratio (eoy) | x | 12.8 | 17.6 | 72.7% | |
Price / Book Value ratio | x | 1.6 | 2.6 | 61.1% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 63 | 37,530.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 4 | 41,636.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 132 | 16,855.0% | |
Other income | Rs m | 256 | 0 | 82,612.9% | |
Total revenues | Rs m | 22,427 | 132 | 17,010.9% | |
Gross profit | Rs m | 2,257 | 4 | 52,117.8% | |
Depreciation | Rs m | 462 | 1 | 59,948.1% | |
Interest | Rs m | 165 | 1 | 28,396.6% | |
Profit before tax | Rs m | 1,887 | 3 | 57,166.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 0 | 105,340.4% | |
Profit after tax | Rs m | 1,391 | 3 | 49,166.1% | |
Gross profit margin | % | 10.2 | 3.3 | 309.0% | |
Effective tax rate | % | 26.2 | 14.3 | 183.9% | |
Net profit margin | % | 6.3 | 2.1 | 292.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 23 | 41,755.9% | |
Current liabilities | Rs m | 5,025 | 10 | 52,509.9% | |
Net working cap to sales | % | 20.9 | 10.3 | 202.7% | |
Current ratio | x | 1.9 | 2.4 | 79.5% | |
Inventory Days | Days | 43 | 0 | - | |
Debtors Days | Days | 8 | 291 | 2.9% | |
Net fixed assets | Rs m | 11,017 | 11 | 100,615.5% | |
Share capital | Rs m | 587 | 45 | 1,310.2% | |
"Free" reserves | Rs m | 14,490 | -20 | -71,485.4% | |
Net worth | Rs m | 15,077 | 25 | 61,464.3% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 34 | 60,656.6% | |
Interest coverage | x | 12.5 | 6.7 | 186.2% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 3.9 | 27.8% | |
Return on assets | % | 7.5 | 10.0 | 75.4% | |
Return on equity | % | 9.2 | 11.5 | 80.1% | |
Return on capital | % | 13.6 | 15.8 | 86.1% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 29 | 20,778.2% | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 29 | -426.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -3 | -38,815.9% | |
From Investments | Rs m | -1,200 | -1 | 117,647.1% | |
From Financial Activity | Rs m | -41 | NA | - | |
Net Cashflow | Rs m | -18 | -4 | 442.3% |
Indian Promoters | % | 48.2 | 36.9 | 130.5% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 63.1 | 82.1% | |
Shareholders | 130,003 | 3,933 | 3,305.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | UNJHA FORMUL | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.56% | -0.88% | 0.97% |
1-Month | 5.64% | 11.98% | 2.08% |
1-Year | -1.14% | 56.00% | 55.37% |
3-Year CAGR | -12.91% | 28.84% | 15.04% |
5-Year CAGR | 16.34% | 12.34% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the UNJHA FORMUL share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of UNJHA FORMUL the stake stands at 36.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of UNJHA FORMUL.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
UNJHA FORMUL paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of UNJHA FORMUL.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.